Cargando…
CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas
Somatic mutations affecting CREBBP and EP300 are a hallmark of Diffuse Large B Cell Lymphoma (DLBCL). These mutations are frequently monoallelic, within the histone acetyltransferase (HAT) domain and usually mutually exclusive, suggesting that they might affect a common pathway and their residual WT...
Autores principales: | Veazey, Kylee J., Cheng, Donghang, Lin, Kevin, Villarreal, Oscar D., Gao, Guozhen, Perez-Oquendo, Mabel, Van, Hieu T., Stratton, Sabrina A., Green, Michael, Xu, Han, Lu, Yue, Bedford, Mark T., Santos, Margarida Almeida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688486/ https://www.ncbi.nlm.nih.gov/pubmed/32576962 http://dx.doi.org/10.1038/s41375-020-0908-8 |
Ejemplares similares
-
Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors
por: Crawford, McKenna C., et al.
Publicado: (2023) -
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function
por: Kumar, Manish, et al.
Publicado: (2021) -
Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice
por: Zheng, Fei, et al.
Publicado: (2016) -
CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells
por: Bommi-Reddy, Archana, et al.
Publicado: (2022) -
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023)